16+
Major trials tracked
Respiratory · Live ClinicalTrials.gov data
Nerandomilast clinical trial pipeline
The timeline below tracks the 16 largest phase 2–4 nerandomilast trials on ClinicalTrials.gov by enrolment, 8 of them actively recruiting. The next phase 3 primary completion among them is expected Apr 2027. Refreshed daily. Add up to four competitors to compare pipelines side by side.
10
Phase 3 trials
8
Actively recruiting
Apr 2027
Next phase 3 primary completion
7,157
Participants across trials
Boehringer Ingelheim
Lead sponsor by trial count
nerandomilast (16)14 active2022–2031
nerandomilast
'22
'23
'24
'25
'26
'27
'28
'29
'30
'31
nerandomilast
A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)P3
A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)P3
CONQUESTP2
FIBRONEER™-ONP3
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)P2
A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic DiseasesP3
MERCURION-IPFP3
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary FibrosisP2
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary FibrosisP3
ARGiNAUTP2
NERAM-PFP4
This Study Evaluates the Safety, Target Engagement, and Preliminary Efficacy of Galunisertib (TGF-βR1/ALK5 Inhibitor)Combined With Nerandomilast (PDE4 Inhibitor) in GREM2-positive ALS, a Biomarker-defined Subgroup Hypothesized to Reflect Heightened TGF-β/SMAD-driven Astrocytic and Fibrotic SignalingP2
A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)P3
VERANDA™-SScP3
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease ProgressionP3
VERANDA™-IIMP3
Upcoming readouts
14 ahead · nerandomilast
Select a trial to load its full ClinicalTrials.gov record.
Key nerandomilast trials
Top 12 of the 16 tracked phase 2–4 trials, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.
Track nerandomilast with ComplyRx
Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.
Related drug pipelines
FAQ
- How many clinical trials are running for nerandomilast?
- ClinicalTrials.gov lists more than 16 phase 2–4 nerandomilast trials. This page tracks the 16 largest by enrolment: 5 phase 2, 10 phase 3, and 1 phase 4 among them, with 8 actively recruiting. Updated daily.
- Where does this data come from?
- All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
- Can I compare nerandomilast against other drugs?
- Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
